Work

Oral Forodesine (Bcx-1777) Is Clinically Active in Refractory Cutaneous T-Cell Lymphoma: Results of a Phase I/II Study.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.2467.2467

Authors: Madeleine Duvic, Andres Forero-Torres, Francine Foss, Elsie A. Olsen, Youn Kim

Institutions: The University of Texas MD Anderson Cancer Center, University of Alabama at Birmingham, Yale Cancer Center, Duke University, Duke Medical Center, Stanford Medicine, Stanford University

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2559795073

FWCI: 2.471

Cites:

Cited by: 28

Related to: 10